BMS-488043 is a novel and unique oral small molecule HIV fusion inhibitor that inhibits the attachment of Human Immunodeficiency Virus type 1 (HIV-1) to CD4(+) lymphocytes.BMS-488043 is used for the treatment of immune disorders, infections, and genitourinary disorders, and can be used in the study of HIV infect
Molecular Weight:
422.43
Purity:
99.95%
CAS Number:
[452296-83-2]
Formula:
C22H22N4O5
Target:
HIV Protease
* VAT and and shipping costs not included. Errors and price changes excepted